Clinical significance of community- and healthcare-acquired carbapenem-resistant Enterobacteriaceae isolates

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Tang, Hung Jen ^a,b   Hsieh, Cheng Fang ^c   Chang, Ping Chin ^a   Chen, Jyh Jou ^a   Lin, Yu Hsiu ^a   Lai, Chih Cheng ^a   Chao, Chien Ming ^a,d   Chuang, Yin Ching ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERTAPENEM; FLOMOXEF; GENTAMICIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CENTRAL VENOUS CATHETER; COMMUNITY ACQUIRED INFECTION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; FOLEY BALLOON CATHETER; HEALTHCARE ASSOCIATED INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; NONHUMAN; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROBACTERIACEAE; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 84962191050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151897     Document Type: Article

References (26)

1. Freeman R, Moore LS, Charlett A, Donaldson H., Holmes AH. Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data. J Antimicrob Chemother 2015;(4:):1212-1218. doi: 10.1093/jac/dku500 PMID: 25525198
2. Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceaeinthe United States. Expert Rev Anti Infect Ther 2014; 12(5):565-580. doi: 10.1586/14787210.2014.902306 PMID: 24666262
3. Gupta N, Limbago BM, Patel J.B., Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53(1):60-7. doi: 10.1093/cid/cir202 PMID: 21653305
4. Lazarovitch T, Amity K, Coyle J.R., Ackerman B., Tal-Jasper R, Ofer-Friedman H, et al. The complex epidemiology of carbapenem-resistant enterobacter infections: a multicenter descriptive analysis. Infect Control Hosp Epidemiol 2015; 36(11):1283-1291. doi: 10.1017/ice.2015.186 PMID: 26399907
5. Temkin E, Adler A, Lerner A., Carmeli Y. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann NY Acad Sci 2014; 1323:22-42. doi: 10.1111/nyas.12537 PMID: 25195939
6. Thaden JT, Lewis SS, Hazen K.C., Huslage K., Fowler VG Jr, Moehring RW, et al. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 2014; 35(8):978-983. doi: 10.1086/677157 PMID: 25026612
7. Yamamoto M, Pop-Vicas AE. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care 2014; 18(3):229. doi: 10.1186/cc13949 PMID: 25041592
8. Chang YY, Chuang YC, Siu L.K., Wu TL, Lin JC, Lu PL, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect 2015; 48(2):219-225. doi: 10.1016/j.jmii.2014.05.010 PMID: 25074627
9. Lai CC, Wu UI, Wang J.T., Chang SC. Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan. J Formos Med Assoc. 2013; 112 (8):492-496. doi: 10.1016/j.jfma.2012.09.021 PMID: 24016614
10. Lee CH, Su LH, Li C.C., Chien CC, Tang YF, Liu JW. Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrob Agents Chemother 2010; 54(12):5395-5398. doi: 10.1128/AAC.00083-10 PMID: 20855742
11. Liu YF, Yan JJ, Ko W.C., Tsai SH, Wu JJ. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 2008; 61(5):1020-1023. doi: 10.1093/jac/dkn049 PMID: 18292097
12. Ma L, Lu PL, Siu L.K., Hsieh MH. Moleculartypingand resistance mechanisms of imipenem-non-sus-ceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 2013; 62(Pt 1):101-107. doi: 10.1099/jmm.0.050492-0 PMID: 23002067
13. Sheng WH, Badal RE, Hsueh PR. Distribution of extended-spectrum beta-lactamases, AmpC beta-lac-tamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013; 57(7):2981-2988. doi: 10.1128/AAC.00971-12 PMID: 23587958
14. Wang JT, Wu UI, Lauderdale T.L., Chen MC, Li SY, Hsu LY, et al. Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. PLoS One. 2015; 10(3):e0121668. doi: 10.1371/journal.pone.0121668 PMID: 25794144
15. Yang FC, Yan JJ, Hung K.H., Wu JJ. Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital. J Clin Microbiol 2012; 50(2):223-226. doi: 10.1128/JCM.01263-11 PMID: 22135256
16. Tan CK, Lai CC, Wang J.Y., Lin SH, Liao CH, Huang YT, et al. Bacteremia caused by non-faecalis and non-faecium enterococcus species at a medical center in Taiwan, 2000 to 2008. J Infect. 2010; 61 (1):34-43. doi: 10.1016/j.jinf.2010.04.007 PMID: 20433865
17. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 22nd informational supplement M100-S22. Wayne, PA: CLSI; 2012.
18. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: appoved standard - eighth edition M07-A8. Wayne, PA: CLSI; 2009.
19. Bhargava A, Hayakawa K, Silverman E., Haider S, Alluri KC, Datla S, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014; 35(4):398-405. doi: 10.1086/675614 PMID: 24602945
20. Kritsotakis EI, Tsioutis C, Roumbelaki M., Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-(beta)-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother 2011; 66(6):1383-1391. doi: 10.1093/jac/dkr116 PMID: 21454344
21. Lee GC, Lawson KA, Burgess DS. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study. Ann Pharmacother 2013; 47(9):1115-1121. doi: 10.1177/1060028013503120 PMID: 24259725
22. Liu SW, Chang HJ, Chia J.H., Kuo AJ, Wu TL, Lee MH. Outcomes and characteristics of ertapenem-non-susceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect 2012; 45(2):113-119. doi: 10.1016/j.jmii.2011.09.026 PMID: 22154994
23. Patel N, Harrington S, Dihmess A., Woo B, Masoud R, Martis P., et al. Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae. J Antimicrob Chemother 2011; 66(7):1600-1608. doi: 10.1093/jac/dkr156 PMID: 21508008
24. Schechner V, Kotlovsky T, Tarabeia J., Kazma M, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011; 32(5):497-503. doi: 10.1086/659762 PMID: 21515981
25. Ling ML, Tee YM, Tan S.G., Amin IM, How KB, Tan KY, et al. Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control 2015; 4:26. doi: 10.1186/s13756-015-0066-3 PMID: 26106476
26. Xu Y, Gu B, Huang M., Liu H, Xu T, Xia W., et al. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia. JThorac Dis 2015; 7(3):376-385. doi: 10.3978/j.issn.2072-1439.2014.12.33 PMID: 25922715